1. Home
  2. BBOT

as 10-24-2025 3:53pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Founded: 2016 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 902.8M IPO Year: N/A
Target Price: $25.00 AVG Volume (30 days): 211.1K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -268.56 EPS Growth: N/A
52 Week Low/High: $8.70 - $13.18 Next Earning Date: 11-26-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest BridgeBio Oncology Therapeutics Inc. Common Stock News

BBOT Breaking Stock News: Dive into BBOT Ticker-Specific Updates for Smart Investing

All BBOT News

Share on Social Networks: